ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1352

Similar Delivery Outcomes in Pregnant Patients with and Without Takayasu Arteritis – A Nationwide Inpatient Database Study

Yanint Raksadawan1, Aravind Polam1, Nattanicha Chaisrimaneepan2 and Sabahat Usmani1, 1Weiss Memorial Hospital, Chicago, IL, 2Texas Tech University Health Sciences, Lubbock, TX

Meeting: ACR Convergence 2023

Keywords: Administrative Data, Epidemiology, pregnancy, Takayasu.s arteritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 13, 2023

Title: (1345–1364) Reproductive Issues in Rheumatic Disorders Poster II

Session Type: Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Takayasu’s arteritis (TA) is a large vessel vasculitis which affects women of reproductive age. There is limited information about the effect of TA on pregnancy. We ran an analysis in pregnant women with an already established diagnosis of TA in an effort to determine the effect of TA on delivery outcomes.

Methods: We queried the National Inpatient Sample database in the period between 2016 – 2019. Patients who were admitted for delivery were identified and stratified based on the presence of diagnosis of TA. The adjusted odds ratios (aOR) of in-hospital outcomes and resource utilization were calculated using chi-square statistics in software STATA v.17.

Results: Of 1.44e+07 hospitalizations for pregnancy between 2016-2019; 120 pregnant patients had TA. The mean age of TA patients was older (31 vs. 29, p-value 0.04). Patients with TA had significantly higher rates of gestational hypertension (15.83% vs 6.4%, p-value 0.03), thyroid disorders (12.5% vs 4.14%, p-value 0.04), genitourinary infections (8.3% vs 2.4%, p-value 0.05) and longer length of stay (3.7 vs 2.6 days, p-value 0.016) compared to controls. The risk of pre-eclampsia trended higher, however was statistically insignificant (aOR 2, 95% CI 0.59-7.0, p-value 0.26). There was no difference in the rate of amniotic or placental disorders, ante/intra/postpartum hemorrhage, cord disorders, prolonged/preterm/postdate pregnancy or fetal stress.

Conclusion: While TA patients had a significantly higher rate of comorbidities: gestational hypertension, thyroid disorders, and increased incidence of genitourinary infections, TA does not seem to cause adverse outcomes during the delivery period. Interestingly, TA patients were older than non-TA patients.

Supporting image 1

Supporting image 2


Disclosures: Y. Raksadawan: None; A. Polam: None; N. Chaisrimaneepan: None; S. Usmani: None.

To cite this abstract in AMA style:

Raksadawan Y, Polam A, Chaisrimaneepan N, Usmani S. Similar Delivery Outcomes in Pregnant Patients with and Without Takayasu Arteritis – A Nationwide Inpatient Database Study [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/similar-delivery-outcomes-in-pregnant-patients-with-and-without-takayasu-arteritis-a-nationwide-inpatient-database-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/similar-delivery-outcomes-in-pregnant-patients-with-and-without-takayasu-arteritis-a-nationwide-inpatient-database-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology